|
1
|
Cekic C and Linden J: Purinergic
regulation of the immune system. Nat Rev Immunol. 16:177–192. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Idzko M, Ferrari D and Eltzschig HK:
Nucleotide signalling during inflammation. Nature. 509:3103172014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ni NC, Yan D, Ballantyne LL,
Barajas-Espinosa A, St Amand T, Pratt DA and Funk CD: A selective
cysteinyl leukotriene receptor 2 antagonist blocks myocardial
ischemia/reperfusion injury and vascular permeability in mice. J
Pharmacol Exp Ther. 339:768–778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang XQ, Zhang XY, Wang XR, Yu SY, Fang
SH, Lu YB, Zhang WP and Wei EQ: Transforming growth factor
β1-induced astrocyte migration is mediated in part by activating
5-lipoxygenase and cysteinyl leukotriene receptor 1. J
Neuroinflammation. 9:1452012. View Article : Google Scholar
|
|
5
|
Zhang XY, Wang XR, Xu DM, Yu SY, Shi QJ,
Zhang LH, Chen L, Fang SH, Lu YB, Zhang WP and Wei EQ: HAMI 3379, a
CysLT2 receptor antagonist, attenuates ischemia-like neuronal
injury by inhibiting microglial activation. J Pharmacol Exp Ther.
346:328–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi QJ, Wang H, Liu ZX, Fang SH, Song XM,
Lu YB, Zhang WP, Sa XY, Ying HZ and Wei EQ: HAMI 3379, a CysLT2R
antagonist, dose- and time-dependently attenuates brain injury and
inhibits microglial inflammation after focal cerebral ischemia in
rats. Neuroscience. 291:53–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ghosh A, Chen F, Thakur A and Hong H:
Cysteinyl leukotrienes and their Receptors: Emerging therapeutic
targets in central nervous system disorders. CNS Neurosci Ther.
22:943–951. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Daniele S, Trincavelli ML, Gabelloni P,
Lecca D, Rosa P, Abbracchio MP and Martini C: Agonist-induced
desensitization/resensitization of human G protein-coupled receptor
17: A functional cross-talk between purinergic and
cysteinyl-leukotriene ligands. J Pharmacol Exp Ther. 338:559–567.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ciana P, Fumagalli M, Trincavelli ML,
Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V,
Gelosa P, et al: The orphan receptor GPR17 identified as a new dual
uracil nucleotides/ cysteinyl-leukotrienes receptor. EMBO J.
25:4615–4627. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Temporini C, Ceruti S, Calleri E, Ferrario
S, Moaddel R, Abbracchio MP and Massolini G: Development of an
immobilized GPR17 receptor stationary phase for binding
determination using frontal affinity chromatography coupled to mass
spectrometry. Anal Biochem. 384:123–129. 2009. View Article : Google Scholar
|
|
11
|
Marucci G, Dal Ben D, Lambertucci C,
Santinelli C, Spinaci A, Thomas A, Volpini R and Buccioni M: The G
protein-coupled receptor GPR17: Overview and update. ChemMedChem.
11:2567–2574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cosentino S, Castiglioni L, Colazzo F,
Nobili E, Tremoli E, Rosa P, Abbracchio MP, Sironi L and Pesce M:
Expression of dual nucleotides/cysteinyl-leukotrienes receptor
GPR17 in early trafficking of cardiac stromal cells after
myocardial infarction. J Cell Mol Med. 18:1785–1796. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franke H, Parravicini C, Lecca D, Zanier
ER, Heine C, Bremicker K, Fumagalli M, Rosa P, Longhi L, Stocchetti
N, et al: Changes of the GPR17 receptor, a new target for
neurorepair, in neurons and glial cells in patients with traumatic
brain injury. Purinergic Signal. 9:451–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lecca D, Trincavelli ML, Gelosa P, Sironi
L, Ciana P, Fumagalli M, Villa G, Verderio C, Grumelli C, Guerrini
U, et al: The recently identified P2Y‑like receptor GPR17 is a
sensor of brain damage and a new target for brain repair. PLoS One.
3:e35792008. View Article : Google Scholar
|
|
15
|
Boda E, Viganò F, Rosa P, Fumagalli M,
Labat-Gest V, Tempia F, Abbracchio MP, Dimou L and Buffo A: The
GPR17 receptor in NG2 expressing cells: Focus on in vivo cell
maturation and participation in acute trauma and chronic damage.
Glia. 59:1958–1973. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ren H, Cook JR, Kon N and Accili D: Gpr17
in AgRP neurons regulates feeding and sensitivity to insulin and
leptin. Diabetes. 64:3670–3679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao B, Zhao CZ, Zhang XY, Huang XQ, Shi
WZ, Fang SH, Lu YB, Zhang WP and Wei EQ: The new P2Y-like receptor
G protein-coupled receptor 17 mediates acute neuronal injury and
late microgliosis after focal cerebral ischemia in rats.
Neuroscience. 202:42–57. 2012. View Article : Google Scholar
|
|
18
|
Ceruti S, Villa G, Genovese T, Mazzon E,
Longhi R, Rosa P, Bramanti P, Cuzzocrea S and Abbracchio MP: The
P2Y-like receptor GPR17 as a sensor of damage and a new potential
target in spinal cord injury. Brain. 132:2206–2218. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fumagalli M, Lecca D and Abbracchio MP:
CNS remyelination as a novel reparative approach to
neurodegenerative diseases: The roles of purinergic signaling and
the P2Y-like receptor GPR17. Neuropharmacology. 104:82–93. 2016.
View Article : Google Scholar
|
|
20
|
Chen Y, Wu H, Wang S, Koito H, Li J, Ye F,
Hoang J, Escobar SS, Gow A, Arnett HA, et al: The
oligodendrocyte-specific G protein-coupled receptor GPR17 is a
cell-intrinsic timer of myelination. Nat Neurosci. 12:1398–1406.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Z, Ou Y, Lin L, You N, Liu X, Li H, Ma
Y, Cao L, Han Y, Liu M, et al: Olig2-targeted G-protein-coupled
receptor Gpr17 regulates oligodendrocyte survival in response to
lysolecithin-induced demyelination. J Neurosci. 36:10560–10573.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Simon K, Hennen S, Merten N, Blättermann
S, Gillard M, Kostenis E and Gomeza J: The orphan G protein-coupled
receptor GPR17 negatively regulates oligodendrocyte differentiation
via Gαi/o and its downstream effector molecules. J Biol Chem.
291:705–718. 2016. View Article : Google Scholar
|
|
23
|
Coppi E, Maraula G, Fumagalli M, Failli P,
Cellai L, Bonfanti E, Mazzoni L, Coppini R, Abbracchio MP, Pedata F
and Pugliese AM: UDP-glucose enhances outward K(+) currents
necessary for cell differentiation and stimulates cell migration by
activating the GPR17 receptor in oligodendrocyte precursors. Glia.
61:1155–1171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meloni BP, Majda BT and Knuckey NW:
Establishment of neuronal in vitro models of ischemia in 96-well
microtiter strip-plates that result in acute, progressive and
delayed neuronal death. Neuroscience. 108:17–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao B, Zhang M, Han X, Zhang XY, Xing Q,
Dong X, Shi QJ, Huang P, Lu YB, Wei EQ, et al: Cerebral ischemia is
exacerbated by extracellular nicotinamide phosphoribosyltransferase
via a non-enzymatic mechanism. PLoS One. 8:e854032013. View Article : Google Scholar
|
|
26
|
Huang XJ, Zhang WP, Li CT, Shi WZ, Fang
SH, Lu YB, Chen Z and Wei EQ: Activation of CysLT receptors induces
astrocyte proliferation and death after oxygen-glucose deprivation.
Glia. 56:27–37. 2008. View Article : Google Scholar
|
|
27
|
Ni M and Aschner M: Neonatal rat primary
microglia: Isolation, culturing, and selected applications. Curr
Protoc Toxicol Chapter 12: Unit. 12:172010.
|
|
28
|
Goldberg MP and Choi DW: Combined oxygen
and glucose deprivation in cortical cell culture: Calcium-dependent
and calcium-independent mechanisms of neuronal injury. J Neurosci.
13:3510–3524. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Daniele S, Lecca D, Trincavelli ML, Ciampi
O, Abbracchio MP and Martini C: Regulation of PC12 cell survival
and differentiation by the new P2Y-like receptor GPR17. Cell
Signal. 22:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qi LL, Lu YB, Shi WZ, Zhao CZ, Zhang YM,
Chen LP, Zhang LH, Fang SH, Bao JF, Shen JG and Wei EQ: Preparation
and identification of a polyclonal antibody against novel cysteinyl
leukotriene receptor GPR17. Zhejiang Da Xue Xue Bao Yi Xue Ban.
38:357–361. 2009.In Chinese. PubMed/NCBI
|
|
31
|
Zhang Z, Luo J, Huang J, Liu Z, Fang S,
Zhang WP, Wei E and Lu Y: Leukotriene D4 activates BV2 microglia in
vitro. Zhejiang Da Xue Xue Bao Yi Xue Ban. 42:253–260. 2013.In
Chinese. PubMed/NCBI
|
|
32
|
Neher JJ, Neniskyte U, Hornik T and Brown
GC: Inhibition of UDP/P2Y6 purinergic signaling prevents
phagocytosis of viable neurons by activated microglia in vitro and
in vivo. Glia. 62:1463–1475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qi AD, Harden TK and Nicholas RA: Is GPR17
a P2Y/leukotriene receptor? examination of uracil nucleotides,
nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
J Pharmacol Exp Ther. 347:38–46. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Norregaard K, Benned-Jensen T and
Rosenkilde MM: EBI2, GPR18 and GPR17-three structurally related,
but biologically distinct 7TM receptors. Curr Top Med Chem.
11:618–628. 2011. View Article : Google Scholar
|
|
35
|
Benned-Jensen T and Rosenkilde MM:
Distinct expression and ligand‑binding profiles of two
constitutively active GPR17 splice variants. Br J Pharmacol.
159:1092–1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hennen S, Wang H, Peters L, Merten N,
Simon K, Spinrath A, Blättermann S, Akkari R, Schrage R, Schröder
R, et al: Decoding signaling and function of the orphan G
protein-coupled receptor GPR17 with a small-molecule agonist. Sci
Signal. 6:ra932013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Simon K, Merten N, Schröder R, Hennen S,
Preis P, Schmitt NK, Peters L, Schrage R, Vermeiren C, Gillard M,
et al: The orphan receptor Gpr17 Is unresponsive to
uracil-nucleotides and cysteinyl-leukotrienes. Mol Pharmacol.
91:518–532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boccazzi M, Lecca D, Marangon D, Guagnini
F, Abbracchio MP and Ceruti S: A new role for the P2Y-like GPR17
receptor in the modulation of multipotency of oligodendrocyte
precursor cells in vitro. Purinergic Signal. 12:661–672. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harden TK: Enigmatic GPCR finds a
stimulating drug. Sci Signal. 6:pe342013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fumagalli M, Bonfanti E, Daniele S,
Zappelli E, Lecca D, Martini C, Trincavelli ML and Abbracchio MP:
The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by
intertwining mTOR with G protein-coupled receptor kinase 2 in the
regulation of GPR17 receptor desensitization. Glia. 63:2327–2339.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim JY, Kim N and Yenari MA: Mechanisms
and potential therapeutic applications of microglial activation
after brain injury. CNS Neurosci Ther. 21:309–319. 2015. View Article : Google Scholar :
|
|
42
|
Ma Y, Wang J, Wang YA and Yang GY: The
biphasic function of microglia in ischemic stroke. Prog Neurobiol.
157:247–272. 2017. View Article : Google Scholar
|
|
43
|
Yang X, Lou Y, Liu G, Wang X, Qian Y, Ding
J, Chen S and Xiao Q: Microglia P2Y6 receptor is related to
Parkinson's disease through neuroinflammatory process. J
Neuroinflammation. 14:382017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Block ML, Zecca L and Hong JS:
Microglia-mediated neurotoxicity: Uncovering the molecular
mechanisms. Nat Rev Neurosci. 8:57–69. 2007. View Article : Google Scholar
|
|
45
|
Koizumi S, Shigemoto-Mogami Y, Nasu-Tada
K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S
and Inoue K: UDP acting at P2Y6 receptors is a mediator of
microglial phagocytosis. Nature. 446:1091–1095. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Günther A, Manaenko A, Franke H, Dickel T,
Berrouschot J, Wagner A, Illes P and Reinhardt R: Early biochemical
and histological changes during hyperbaric or normobaric
reoxygenation after in vitro ischaemia in primary corticoencephalic
cell cultures of rats. Brain Res. 946:130–138. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lazarowski ER, Shea DA, Boucher RC and
Harden TK: Release of cellular UDP-glucose as a potential
extracellular signaling molecule. Mol Pharmacol. 63:1190–1197.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kreda SM, Seminario-Vidal L, Heusden C and
Lazarowski ER: Thrombin-promoted release of UDP-glucose from human
astrocytoma cells. Br J Pharmacol. 153:1528–1537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhou Y, Wei EQ, Fang SH, Chu LS, Wang ML,
Zhang WP, Yu GL, Ye YL, Lin SC and Chen Z: Spatio-temporal
properties of 5-lipoxygenase expression and activation in the brain
after focal cerebral ischemia in rats. Life Sci. 79:1645–1656.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ciceri P, Rabuffetti M, Monopoli A and
Nicosia S: Production of leukotrienes in a model of focal cerebral
ischaemia in the rat. Br J Pharmacol. 133:1323–1329. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Maekawa A, Balestrieri B, Austen KF and
Kanaoka Y: GPR17 is a negative regulator of the cysteinyl
leukotriene 1 receptor response to leukotriene D4. Proc Natl Acad
Sci USA. 106:11685–11690. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Maekawa A, Xing W, Austen KF and Kanaoka
Y: GPR17 regulates immune pulmonary inflammation induced by house
dust mites. J Immunol. 185:1846–1854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang
WP, Yu GL, Chu LS and Chen Z: Increased expression of cysteinyl
leukotriene receptor-1 in the brain mediates neuronal damage and
astrogliosis after focal cerebral ischemia in rats. Neuroscience.
140:969–979. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhao CZ, Zhao B, Zhang XY, Huang XQ, Shi
WZ, Liu HL, Fang SH, Lu YB, Zhang WP and Wei EQ: Cysteinyl
leukotriene receptor 2 is spatiotemporally involved in neuron
injury, astrocytosis and microgliosis after focal cerebral ischemia
in rats. Neuroscience. 189:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
